ILEX ONCOLOGY INC
10-Q, EX-27.1, 2000-11-14
MEDICAL LABORATORIES
Previous: ILEX ONCOLOGY INC, 10-Q, EX-11.1, 2000-11-14
Next: SOUTHLAND SEPARATE ACCOUNT L1, S-6, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AS OF SEPTEMBER 30, 2000, AND THE STATEMENT OF OPERATIONS FOR THE PERIOD
THEN ENDED AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          29,214
<SECURITIES>                                   172,369
<RECEIVABLES>                                    8,629
<ALLOWANCES>                                       284
<INVENTORY>                                          0
<CURRENT-ASSETS>                               150,369
<PP&E>                                          10,580
<DEPRECIATION>                                   4,377
<TOTAL-ASSETS>                                 220,491
<CURRENT-LIABILITIES>                           17,037
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           250
<OTHER-SE>                                     197,824
<TOTAL-LIABILITY-AND-EQUITY>                   220,491
<SALES>                                              0
<TOTAL-REVENUES>                                21,559
<CGS>                                                0
<TOTAL-COSTS>                                   38,353
<OTHER-EXPENSES>                                 4,125
<LOSS-PROVISION>                                   120
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (16,347)
<INCOME-TAX>                                       137
<INCOME-CONTINUING>                           (16,484)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (16,484)
<EPS-BASIC>                                     (0.69)
<EPS-DILUTED>                                   (0.69)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission